Finance

Lists
DMP:VIE
Dermapharm Holding SE
€38,70
-0,13%
(-0,050) 1D
22 Okt., 11:00:18 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DMP...
Open
€38,55
High
€38,70
Low
€38,55
Mkt. cap
1,91 mjd
Avg. vol.
0,00
Volume
0,00
Dividend
2,27%
Quarterly dividend
€0,22
Ex-dividend date
29 Jun. 2026
P/E ratio
14,03
52-wk high
€51,20
52-wk low
€32,50
EPS
€2,76
No. of employees
4 k
Open
€38,55
High
€38,70
Low
€38,55
Mkt. cap
1,91 mjd
Avg. vol.
0,00
Volume
0,00
Dividend
2,27%
Quarterly dividend
€0,22
Ex-dividend date
29 Jun. 2026
P/E ratio
14,03
52-wk high
€51,20
52-wk low
€32,50
EPS
€2,76
No. of employees
4 k
News stories
From web sources and news partners
Profile
Dermapharm Holding SE or Dermapharm AG, based in Grünwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations. Wikipedia
About Dermapharm Holding SE
CEOHans-Georg Feldmeier
Employees3,62 k
Founded1991
Headquarters-
SectorPharmaceutical industry
Websiteir.dermapharm.de
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
294,90 m
296,46 m
305,80 m
285,15 m
Cost of goods sold
101,90 m
113,32 m
101,39 m
92,31 m
Cost of revenue
101,90 m
113,32 m
101,39 m
92,31 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
67,31 m
81,14 m
78,76 m
79,38 m
Operating expense
132,40 m
100,78 m
143,59 m
147,60 m
Total operating expenses
234,30 m
214,11 m
244,98 m
239,92 m
Operating income
60,60 m
82,35 m
60,83 m
45,24 m
Other non operating income
5,27 m
-13,11 m
9,84 m
25,81 m
EBT including unusual items
55,16 m
46,16 m
61,51 m
29,95 m
EBT excluding unusual items
55,16 m
57,48 m
61,51 m
59,95 m
Income tax expense
14,05 m
10,01 m
16,38 m
6,79 m
Effective tax rate
25,47%
21,68%
26,63%
22,68%
Other operating expenses
44,04 m
209,00 k
44,44 m
45,10 m
Net income
41,22 m
36,89 m
45,20 m
23,22 m
Net profit margin
13,98%
12,44%
14,78%
8,14%
Earnings per share
-
0,73
-
-
Interest and investment income
5,95 m
-
1,42 m
2,01 m
Interest expense
-16,68 m
-11,02 m
-10,68 m
-12,29 m
Net interest expenses
-10,73 m
-11,02 m
-9,26 m
-10,28 m
Depreciation and amortization charges
21,05 m
19,43 m
20,39 m
23,12 m
EBITDA
81,51 m
89,38 m
81,14 m
97,45 m
Gain or loss from assets sale
19,00 k
63,00 k
90,00 k
31,00 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme